Clinical Trial Update: The LINFU® U.S. Registry for the in the General Population Without Risk Factors

View source ↗

Summary

A clinical trial registry update from Adenocyte, LLC about the LINFU U.S. Registry; the study (NCT06276803) is not yet recruiting and involves pancreatic cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma
• Pancreatic Dysplasia

Snippet

Sponsor: Adenocyte, LLC | Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Status: NOT_YET_RECRUITING